Home > Insider Trading > Filing (0001209191-20-050081)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1322505	Albireo Pharma Inc.	ALBO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1741553	Jason Duncan	C/O Albireo Pharma Inc. 10 Post Office Square, Suite 1000 Boston MA 02109	Chief Legal Officer And Gc	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-09-08	3,500	$24.04	7,870	No	4	M	Direct
Common Stock	Disposition	2020-09-08	4,000	$45.55	3,870	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-09-08	3,500	$0.00	3,500	$24.04

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
19,500		2029-01-21	No	4	M	Direct

Footnotes

Represents 4,745 shares of common stock and 3,125 restricted stock units.
Shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2019.
Represents 745 shares of common stock and 3,125 restricted stock units.
This option vested as to 25% of the shares on January 22, 2020 with the remainder vesting in equal installments every three months thereafter, beginning on April 22, 2020 and ending on January 22, 2023.